Lesion Targeting with 89Zr-IAB2M in Patient with Metastatic Prostate Cancer (image) Society of Nuclear Medicine Share Print E-Mail Caption 99mTc-MDP bone scan (A) shows lesions in vertebrae and ribs. FDG-PET scan (B) shows uptake in left femur and faint uptake in vertebral lesions. 89ZrIAB2M imaging (C) shows more images compared to bone scan or FDG. Credit Neeta Pandit-Taskar, M.D., and Michael J. Morris, M.D., Memorial Sloan Kettering Cancer Center Usage Restrictions include caption & credit information Share Print E-Mail Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.